Pharma BD Deal Intelligence
Nektar Therapeutics / Aerogen, Inc.
2005 · Acquisition/Merger · $32M · Complete
Announcement Sentiment
86
Strongly positive
Nektar agrees to acquire Aerogen (~$32M; $8M cash + $24M stock) for inhaled-liquid pulmonary technology. Closed October 2005.
Key facts
- Announced Aug 15, 2005
- Closed Oct 25, 2005
- Deal value $32M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals